Multifunctional magnetic nanocapsules for dual delivery of siRNA and chemotherapy to MCF-7 cells (Breast cancer cells)
Naunyn-Schmiedeberg's Archives of Pharmacology · 2025
DOI: 10.1007/s00210-025-04381-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Sahar Mohajeri und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Ard.C., Islamic Azad University, Ardabil, Iran. sahar.mohajeri@iau.ac.ir. Hauptthemen laut MEDLINE: RNA, Small Interfering, Paclitaxel, Nanocapsules, Breast Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 100 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
The targeted delivery of nucleic acids and drugs via nanoparticles to damaged cells remains a significant challenge in cancer treatment. This study focused on the bipolar copolymer Fe3O4/chitosan/polycaprolactone (PCL)/polyethylene glycol (PEG)-hyaluronic acid (HA) nanocapsules designed to enhance drug delivery to CD44 receptor-expressing MCF-7 cancer cells. These nanoparticles integrate iron oxide, hydrophilic PEG, biodegradable PCL, cationic chitosan, and hyaluronic acid. The physicochemical properties of the nanoparticles were investigated and confirmed via Fourier transform infrared (FTIR) spectroscopy and differential thermogravimetric (DTG) analysis. After paclitaxel (PTX) and siRNA-FAM loading, the zeta potential, dynamic light scattering (DLS), and scanning electron microscopy (SEM) confirmed the successful synthesis and appropriate structural properties of the nanocapsules. The nanocapsules were measured at approximately 230 nm with a zeta potential of - 2.5 mV. Release studies at pH 5 and 7.4 demonstrated that a lower pH significantly increased the release rates of PTX and siRNA-FAM. Electrophoretic analysis indicated that the nanocapsule coating (controlled-release nanoprotective coating) protected these agents from plasma degradation. An evaluation of the magnetic properties via a vibrating sample magnetometer (VSM) revealed that the iron oxide nanoparticles exhibited desirable magnetic characteristics, with values decreasing from 42.5 to 16.8 emu/g upon encapsulation. Cytotoxicity assessments via the MTT assay indicated the low toxicity (IC50 = 492.7 μg/mL) of the nanocapsules to the MCF-7 cell line. Flow cytometry revealed effective targeted gene transfer, with significant pre- and post-apoptosis rates (18.14% and 15.65%, respectively) for the Fe3O4/chitosan/PCL/PEG-HA/PTX treatment. The agarose gel and fluorescence microscopy results confirmed the superior gene transfer efficiency of the Fe3O4/chitosan/PCL/PEG-HA/siRNA-FAM nanocapsules compared with the controls, which was attributed to their stability and the presence of hyaluronic acid groups. This study presents the first application of these nanocapsules for gene and drug delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Ard.C., Islamic Azad University, Ardabil, Iran. sahar.mohajeri@iau.ac.ir.
- Department of Biology, Ard.C., Islamic Azad University, Ardabil, Iran. yaghoubi_h@iau.ac.ir.
- Department of Agronomy and Plant Breeding, Faculty of Agriculture and Natural Resources, University of Mohaghegh Ardabili, Ardabil, Iran.
ORCID-Profile: Sahar Mohajeri, Hashem Yaghoubi
Zitieren
APA
Mohajeri, S., Yaghoubi, H., Bourang, S., & Noruzpour, M. (2025). Multifunctional magnetic nanocapsules for dual delivery of siRNA and chemotherapy to MCF-7 cells (Breast cancer cells). Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04381-8
Vancouver
Mohajeri S, Yaghoubi H, Bourang S, Noruzpour M. Multifunctional magnetic nanocapsules for dual delivery of siRNA and chemotherapy to MCF-7 cells (Breast cancer cells). Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-04381-8
BibTeX
@article{Mohajeri2025,
author = {Mohajeri, Sahar and Yaghoubi, Hashem and Bourang, Shima and Noruzpour, Mehran},
title = {Multifunctional magnetic nanocapsules for dual delivery of siRNA and chemotherapy to MCF-7 cells (Breast cancer cells)},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2025},
doi = {10.1007/s00210-025-04381-8}
}
EUVIMED